FDG-PET scanning in the management of cancer of the oesophagus and oesophagogastric junction: Early experience with 100 consecutive cases

Irish Journal of Medical Science

Volumn 175, Issue 4, 2006, Pages 48-54

  Malik, V ^a   Keogan, M ^a   Gilham, C ^a   Duffy, G ^b   Ravi, N ^a   Reynolds, John V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b Blackrock Clinic Ireland   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE; IOHEXOL;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST; ESOPHAGUS CANCER; FALSE POSITIVE RESULT; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

EID: 33846890171     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03167967     Document Type: Article

References (34)

1. Enzinger PC, Mayer RJ. Esophageal Cancer. N. Engl J Med, 2003;349: 562-572
2. HulscherJB,Tijssen,Obertop H, van Lanschot JJ. Transthoracic versus transhiatial resection for carcinoma of the esophagus:A meta-analysis. Ann Thorac Surg 2001; 72: 306-13
3. Beahrs OH, Henson DE, Hunter RVP, et al: American Joint Committee on Cancer: Manual for staging of cancer (ed 3). Philadelphia, PA, JB Lippincott, 1998,99 63-67.
4. Sobin LH, Wittekind C: TNM Classification of Malignant Tumours, 6th ed. New York: John Wiley & Sons, 2003.
5. Kumbasar B. Carcinoma of esophagus: radiologic diagnosis and staging. Eur J Radiol 2002;42:170-180.
6. Kelly S, Harris KM, Berry E, et al A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49; 534-9.
7. Bar-Shalom R, Valdiva AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-85.
8. Lightdale CJ. Positron emission tomography: Another useful test for staging esophageal cancer. J Clin Oncol 2000;18:3199-01.
9. Lewis P, griffin S, Marsden P, et al Whole body F-fluorodeoxyglucose positron emission tomography in the preoperative evaluation of lung cancer. Lancet 1994; 344:1265-1266.
10. Adler LP, Crowe JP, al-Kaisi NK, et al Evaluation of breast masses and axillary lymph nodes with (F-18) 2-deoxy-2-fluoro-d-glucose PET. Radiol 1993;187:743-750.
11. Rege S, Maass A, Chaiken L, et al Use of positron emission tomography with fluoro- deoxyglucose in patients with extracranial head and neck tumors. Cancer 1994;74:3047-3058.
12. Newman JS, Francis IR, Kaminski MS, et al Imaging of lymphoma with PET with 2-(F-18)-fluoro-2-deoxy-D-glucose: correlation with CT. Radiol 1994;190:111-116.
13. Di Chiro G. Positron emission tomography using (F-18)fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 1987;22:360-371.
14. Steinert HC, Huch RA, Buck A, et al Malignant melanoma: staging with whole body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiol 1995;195:705-709.
15. Nieweg OE, Pruim J, van Ginkel RJ, et al Fluorine-18-fluorodeoxyglucose PET in soft tissue sarcoma. J Nucl Med 1996;37:257-261
16. Henderik L, van Westreenen MD, Heeren PAM, van Dullemen HM, et al Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest. Surg 2005;9:54-61.
17. Wallace MB, Nietert PJ, Earle C, et al An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography and thoracoscopy/laparoscopy. Ann Thorac Surg 2002;74:1026-32.
18. Kato H, Hiroyuki K, Nakajima M, et al Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002;94:921-928.
19. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell cancer of the esophagus with positron_emission tomograpgy. Ann Thorac Surg. 2001;71:290-294.
20. Wren SM, Stijns P, Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg. 2002;137:1001-1007.
21. Luketich JD, Friedman DM, Weigel TL, et al Evaluation of distant metastases in esphageal cancer: 100 consecutive positron emission tomography scans. Ann Thorc Surg 1999;68:1133-7.
22. Eloubeidi MA, Wallace MB, Reed CE, et al The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: A single center experience. Gastrointest. Endosc. 2001;54:714-9.
23. Parmar KS, Zwischenberger JB, Reeves AL, Waxman I. Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer. Ann Thorac Surg 2002;73:916-20.
24. Meno KV, Dehn TC. Multiport staging laporoscopy in esophageal and cardiac carcinoma. Dis Esophagus 2003;16:295-300.
25. Jamieson GG, Mathew G, Ludeman R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following esophagectomy and problems in reporting its rate. Br J Surg 2004;91:943-97
26. Ellis FHJr., Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1997;113:836-46.
27. Flamen P, Lerut A, Van Cutesm E, et al: Utility of positron emission tomography for the staging of patients with potentially operable esophageal card noma. J Clin Oncol 2000;18:3202-10.
28. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
29. Wahl RL, Hutchins GD, Buchsbaum DJ, et al (F-18)-2-deoxy-2-fluoro-d-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron emission tomography. Cancer 1991;67:1544-50.
30. Block MI, Patterson GA, Sundaresan S, et al Improvement in staging of oesophageal CA with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-7.
31. Fukahagan T, Okazumi S, Koide Y, Zsoho K, Zwnazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med 1998;39:1002-7.
32. Flanagan FL, Dehdashti F, Seigel BA, et al Staging of esophageal cancer with (F-18) fluorodeoxyglucose postron emission tomography. AJR 1997;168:417-24.
33. MRC Trial. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002;359:1727-1733
34. Fiochha F, DiBona D, Schepis F, Licata A, Shahied L, et al Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004; 53:925-930.